Menactra Meningococcal Vaccine in Multan
Packaging Size |
0.5ml
|
Brand |
Menactra
|
Manufacturer |
Sanofi Pasteur
|
Composition |
Meningococcal Vaccine (Group A, C, Y & W-135) (16mcg) + Diphtheria Toxoid (48mcg)
|
Treatment |
Meningococcal disease
|
Product Details:-
Meningococcal (groups A, C, Y and W-135) Polysaccharide Diphtheria toxoid conjugate Vaccine.
1 Dose Vial : Solution for intramuscular injection
Dosing information
Menactra is given as a 0.5ml dose by intramuscular injection. Do not administer Menactra intravenously or subcutaneously.
Primary Vaccination:
- In children 9 through 23 months of age, Menactra is given as a 2-dose series three months apart.
- In people from 2 years old, up to and including 55 years of age, Menactra is given as a single dose.
Booster Vaccination:
- A single booster dose may be given to people from 15 years old, up to and including 55 years of age who are at a continued risk of meningococcal disease, if at least 4 years have elapsed since since receiving a dose of a meningococcal conjugate vaccine.
Reviews
There are no reviews yet.